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Results: In the whole population, CDA Lys27Lys polymorphism sig-
niﬁcantly correlated with better response (P=0.04) and higher haemato-
logical toxicity. In the cisplatin/gemcitabine-treated patients, signiﬁcant 
correlations were observed between CDA Lys27Lys genotype and 
better response, grade >3 neutropenia, as well as with longer TTP and 
OS (P=0.01 and P=0.001, respectively) (Table 1).
Table 1. Correlation between CDA 27 genotype SNP and activity, eﬃcacy 
and haematological toxicity of chemotherapy.
The multivariate analysis conﬁrmed the prognostic signiﬁcance of this 
polymorphism (P=0.02), while no signiﬁcant associations were found 
among ERCC1 and XPD polymorphisms and clinical outcome in this 
group of patients. CDA genotype didn’t result predictive of response 
and toxicity in patients treated with gemcitabine alone.
Conclusions: CDA Lys27Gln polymorphism resulted a predictive 
biomarker of response rate, toxicity, TTP and OS in advanced NSCLC 
patients treated with cisplatin and gemcitabine, thus offering a potential 
new tool for treatment optimization. Enzymatic activity assays on 
blood samples are ongoing to better understand this feature.
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Background: Phospholipase D (PLD) is activated by stimulators of 
vesicle transport, endocytosis, exocyosis, cell migration, and mitosis. 
These cellular biological processes are deregulated in the development 
of various human tumors. The involvement of PLD in tumorigenesis 
suggests that PLD could be valuable targets for therapeutic interven-
tion and phamacogenetics focuses on the prediction of the effect 
of chemotherapy by genetic proﬁling in cancers. Single nucleotide 
polymorphisms (SNPs) are extensively used in case-control studies of 
practically all cancer. The identiﬁcation of polymorphisms of cancer 
patients may help the clinician prescribe the optimal drug combination 
or schedule and predict the response of chemotherapy with accuracy.
Method: The purpose of this study was to analyze genetic polymor-
phisms of phospholipase D1(PLD1) gene as a predictive marker for 
response to chemotherapy in non-small cell lung cancer. 
Results: We identiﬁed two SNPs at the exon 14, one SNP at the exon 
16 and six SNPs at the exon 23. cSNPs of PLD1 was selected ac-
cording to the degree of heterozygosity; (exon 23, rs2668, allele A/C: 
A2668C). The allelic frequencies of A2668C was 70.85 % in 211 non-
small lung cancer patients. The allelic frequencies of A2668C polymor-
phism of responders (partial response) showed signiﬁcant association 
with non-responders (stable disease and progression) to chemotherapy 
(p=0.059, OR=1.739). Also, the genotype frequencies of A2668C poly-
morphism of responders showed signiﬁcant association with non-re-
sponders to chemotherapy (p=0.017, OR=2.198). Between gender and 
smoking on the risk of lung cancer, signiﬁcant association was found in 
genotype frequencies of A2668C polymorphism (p=0.013, OR=2.651). 
Conclusion: From our results, we suggest that PLD1 genetic polymor-
phism (A2668C) might be a predictive marker for response to chemo-
therapy in non-small cell Lung cancer. 
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Background: Previously, we reported that small pulmonary adenocar-
cinomas (tumor diameter 20mm or less) could be classiﬁed according 
to attenuation on high-resolution CT (HRCT) images as either ‘air-con-
taining type’ (‘fair-type’) or ‘solid-density type’ (=’solid-type’) (Lung 
Cancer 36 (2002)). Air-type was deﬁned as having areas where tumor 
opacity on mediastinal window images were half or less than half the 
size of those noted on lung window images. Solid-type was deﬁned as 
having areas where tumor opacity on mediastinal window images was 
greater than half the size of those noted on lung window images. Our 
ﬁndings indicated that there was no microscopic evidence of metastasis 
with air-type nor any relapses nor deaths, after resection. By contrast, 
patients with solid-types demonstrated a poor prognosis. At this time, 
the histopathological characteristics of areas of tumor opacity noted on 
mediastinal window images have not been fully investigated.
Method: We retrospectively reviewed the records and CT scans of 118 
patients, who had undergone surgical resection of peripheral adeno-
carcninomas. All tumor diameters were 20mm or less in size. All 118 
patients had undergone HRCT prior to surgery. HRCT Images were 
acquired by a model X-Vigor/Real or an Aquillion CT scanner (Toshiba 
Medical Systems). High-resolution images of tumors were obtained at 
135kVp at 250mAs with 1-2mm section thicknesses. All images were 
photographed using mediastinal (level, 40HU; width, 400HU) and lung 
(level, -600HU; width, 1600HU) window settings. We analyzed the 
correlation between areas of tumor opacity of mediastinal window im-
ages and the histopathological and the clinical ﬁndings.
Results: Areas of tumor opacity noted on mediastinal window images 
demonstrated ﬁve possible histopathological ﬁndings; 1. collapse (C), 
